SDCL EDGE Acquisition Corporation

C/O Maples, Geroge Town, Grand Cayman, Cayman Islands3 employees

Also known as:

seda-us

seda-wt

seda

sdcl edge acquisition corp

SEDA-UN

SDCL EDGE Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded on February 16, 2021 and is headquartered in New York, NY.

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

No trial phase data available

Trial Status Distribution

No trial data available

Clinical Trials

No trial data available

Approvals

No approval data available

News

UK Launches £18.8 Million Initiative to Transform Nuclear Waste into Precision Cancer Therapies

- The UK has announced a £18.8 million investment to develop targeted alpha therapies using lead-212 extracted from recycled nuclear fuel for precision cancer treatment. - The project, co-led by UK National Nuclear Laboratory and Medicines Discovery Catapult, aims to create an "evergreen" supply of radiopharmaceuticals that directly attack cancer cells while sparing healthy tissue. - A tiny amount of processed material equivalent to a single drop of water in an Olympic-sized swimming pool could potentially treat thousands of cancer patients. - The initiative positions the UK to provide these innovative treatments both domestically and globally, targeting previously untreatable cancers with sustainable nuclear waste utilization.

Nov 18, 2025

Back to Organizations